DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now owns 77,851 shares in the company, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Blake Jeffrey Grayson also recently made the following trade(s):
- On Wednesday, December 18th, Blake Jeffrey Grayson sold 15,588 shares of DocuSign stock. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64.
- On Monday, December 16th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The shares were sold at an average price of $94.77, for a total transaction of $758,160.00.
DocuSign Price Performance
Shares of DOCU opened at $86.73 on Thursday. The company has a market cap of $17.52 billion, a P/E ratio of 17.88, a P/E/G ratio of 7.03 and a beta of 0.89. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm has a 50 day simple moving average of $92.27 and a two-hundred day simple moving average of $76.12.
Institutional Inflows and Outflows
Analyst Ratings Changes
DOCU has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday, December 3rd. HSBC reissued a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Wells Fargo & Company lifted their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th. UBS Group raised their price objective on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Finally, Morgan Stanley upped their target price on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $92.45.
Get Our Latest Stock Report on DocuSign
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.